Skip to main content
SpringerLink
Log in

New Concepts for Early Diagnosis of Coronary Artery Disease

  • Chapter
Cardiovascular Prevention and Rehabilitation

  • 2105 Accesses

Abstract

Cardiovascular diseases are still the number one killer in developed countries. The term “death from cardiovascular disease,” however, includes not only acute myocardial infarction, but also death from chronic ischemic heart disease, stroke, peripheral artery disease, and pulmonary embolism. A more detailed analysis shows that only approximately 18% of the cardiovascular deaths arise from acute myocardial infarction, while a continuously increasing percentage result from chronic ischemic heart disease. Although modern medicine significantly improved the short-term outcome of acute myocardial infarction, it shifted the problem from a decrease in mortality to an increase in morbidity. Therefore, the challenge of modern medicine is not only to further reduce the already declining cardiovascular mortality,1,2 but also to reduce cardiovascular morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 2000; 102:3137–3147.

    PubMed  CAS  Google Scholar 

  2. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101–1107.

    Article  PubMed  Google Scholar 

  3. Silber S. Quantification of coronary artery calcifications in the risk stratification of cardiac events. Dtsch Med Wochenschr 2002;127:2575–2578.

    Article  PubMed  CAS  Google Scholar 

  4. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Executive Summary: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (executive summary). Eur Heart J 2003;24:1601–1610.

    Article  PubMed  Google Scholar 

  5. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Full Version: European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (full version). Eur J Cardiovasc Prev Rehabil 2003;10:S1–S10.

    Article  PubMed  Google Scholar 

  6. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003;290:2292–2300.

    Article  PubMed  CAS  Google Scholar 

  7. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673–2678.

    PubMed  CAS  Google Scholar 

  8. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899–1906.

    PubMed  Google Scholar 

  9. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003;108:2054–2059.

    Article  PubMed  Google Scholar 

  10. Smith SC Jr, Greenland P, Grundy SM. AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary and full version. Circulation 2000;101:111–116 (full version: e116–e122).

    PubMed  Google Scholar 

  11. Oei HH, Vliegenthart R, Hak AE, et al. The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: the Rotterdam Coronary Calcification Study. J Am Coll Cardiol 2002;39:1745–1751.

    Article  PubMed  Google Scholar 

  12. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317–1324.

    Article  PubMed  CAS  Google Scholar 

  13. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510–515.

    PubMed  CAS  Google Scholar 

  14. Abbott RD, Petrovitch H, Rodriguez BL, et al. Ankle/brachial blood pressure in men > 70 years of age and the risk of coronary heart disease. Am J Cardiol 2000;86:280–284.

    Article  PubMed  CAS  Google Scholar 

  15. Otah KE, Madan A, Otah E, Badero O, Clark LT, Salifu MO. Usefulness of an abnormal anklebrachial index to predict presence of coronary artery disease in African-Americans. Am J Cardiol 2004;93:481–483.

    Article  PubMed  Google Scholar 

  16. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol 2002;90:953–958.

    Article  PubMed  Google Scholar 

  17. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14–22.

    Article  PubMed  CAS  Google Scholar 

  18. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151:478–487.

    PubMed  CAS  Google Scholar 

  19. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 1997;146:483–494.

    PubMed  CAS  Google Scholar 

  20. Mathiesen EB, Bonaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromso study. Circulation 2001;103:2171–2175.

    PubMed  CAS  Google Scholar 

  21. Honda O, Sugiyama S, Kugiyama K, et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol 2004;43:1177–1184.

    Article  PubMed  Google Scholar 

  22. van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004;109:1089–1094.

    Article  PubMed  Google Scholar 

  23. Botnar RM, Stuber M, Kissinger KV, Kim WY, Spuentrup E, Manning WJ. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000;102:2582–2587.

    PubMed  CAS  Google Scholar 

  24. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102:506–510.

    PubMed  CAS  Google Scholar 

  25. Helft G, Worthley SG, Fuster V, et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation 2002;105:993–998.

    Article  PubMed  Google Scholar 

  26. Kim WY, Stuber M, Bornert P, Kissinger KV, Manning WJ, Botnar RM. Three-dimensional blackblood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 2002;106:296–299.

    Article  PubMed  Google Scholar 

  27. Kramer CM, Cerilli LA, Hagspiel K, DiMaria JM, Epstein FH, Kern JA. Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circulation 2004;109:1016–1021.

    Article  PubMed  Google Scholar 

  28. Schmermund A, Erbel R, Silber S. Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2,030 persons with no symptoms of coronary artery disease. The MUNICH registry. Am J Cardiol 2002;90:168–173.

    Article  PubMed  CAS  Google Scholar 

  29. Stanford W, Thompson BH, Burns TL, Heery SD, Burr MC. Coronary artery calcium quantification at multi-detector row helical CT versus electron-beam CT. Radiology 2004;230:397–402.

    Article  PubMed  Google Scholar 

  30. Becker CR, Jakobs TF, Aydemir S, et al. Helical and single-slice conventional CT versus electron beam CT for the quantification of coronary artery calcification. AJR Am J Roentgenol 2000;174:543–547.

    PubMed  CAS  Google Scholar 

  31. Morin RL, Gerber TC, McCollough CH. Radiation dose in computed tomography of the heart. Circulation 2003;107:917–922.

    Article  PubMed  Google Scholar 

  32. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998;31:126–133.

    Article  PubMed  CAS  Google Scholar 

  33. Silber S, Shemesh J, Weg N, Yoon HC. Multicentre age and gender distribution of coronary artery calcification as measured by four-slice computed tomography in 5,345 people. Eur Heart J 2003; 24(Suppl):570.

    Article  Google Scholar 

  34. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;92:2157–2162.

    PubMed  CAS  Google Scholar 

  35. Burke AP, Taylor A, Farb A, Malcom GT, Virmani R. Coronary calcification: insights from sudden coronary death victims. Z Kardiol 2000;89(Suppl 2):49–53.

    Article  PubMed  Google Scholar 

  36. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation 2001;104:1682–1687.

    PubMed  CAS  Google Scholar 

  37. Leber AW, Knez A, Becker A, et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am Coll Cardiol 2004;43:1241–1247.

    Article  PubMed  Google Scholar 

  38. Achenbach S, Moselewski F, Ropers D, et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation 2004;109:14–17.

    Article  PubMed  Google Scholar 

  39. Schroeder S, Kopp AF, Baumbach A, et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol 2001;37:1430–1435.

    Article  PubMed  CAS  Google Scholar 

  40. Erbel R, Schmermund A, Stang A, et al. The “Heinz Nixdorf RECALL Study”: Improvement of prediction of risk for myocardial infarction based on known and newer risk factors as well on modern imaging and non-imaging methods. Z Kardiol 2004;93(Suppl. 3):III/244.

    Google Scholar 

  41. Schmermund A, Möhlenkamp S, Stang A, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 2002;144:212–218.

    Article  PubMed  Google Scholar 

  42. The EUROASPIRE I and II Group, Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357:995–1001.

    Article  Google Scholar 

  43. The NCEP Expert Panel, Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015–3023.

    Article  Google Scholar 

  44. The NCEP Expert Panel, National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1333–1445.

    Google Scholar 

  45. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998;19:1434–1503.

    Article  Google Scholar 

  46. The NCEP Expert Panel, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.

    Article  Google Scholar 

  47. Grundy SM, Bazzarre T, Cleeman J, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation 2000;101:e3–e11.

    PubMed  CAS  Google Scholar 

  48. Hennekens CH, D’Agostino RB. Global risk assessment for cardiovascular disease and astute clinical judgement. Eur Heart J 2003;24:1899–1900.

    Article  PubMed  Google Scholar 

  49. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 2004;25:484–491.

    Article  PubMed  Google Scholar 

  50. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105:310–315.

    Article  PubMed  Google Scholar 

  51. Brindle P, Emberson J, Lampe F, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327:1267.

    Article  PubMed  Google Scholar 

  52. Empana JP, Ducimetiere P, Arveiler D, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003;24:1903–1911.

    Article  PubMed  CAS  Google Scholar 

  53. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.

    Article  PubMed  CAS  Google Scholar 

  54. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003;290:891–897.

    Article  PubMed  Google Scholar 

  55. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898–904.

    Article  PubMed  Google Scholar 

  56. Böger GI, Hoopmann M, Busse R, Budinger M, Welte T, Böger RH, Drug therapy of coronary heart disease — are therapeutic guidelines being paid attention to? Z Kardiol 2003;92:466–475.

    PubMed  Google Scholar 

  57. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004;109:551–556.

    Article  PubMed  Google Scholar 

  58. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655–663.

    Article  PubMed  CAS  Google Scholar 

  59. Zylberstein DE, Bengtsson C, Bjorkelund C, et al. 4-year follow-up of the population study of women in Gothenburg. Circulation 2004;109:601–606.

    Article  PubMed  CAS  Google Scholar 

  60. Ariyo AA, Thach C, Tracy R. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 2003;349:2108–2115.

    Article  PubMed  CAS  Google Scholar 

  61. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026–2033.

    Article  PubMed  CAS  Google Scholar 

  62. Arroyo-Espliguero R, Avanzas P, Cosin-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004;25:401–408.

    Article  PubMed  CAS  Google Scholar 

  63. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973–979.

    Article  PubMed  CAS  Google Scholar 

  64. Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004;109:1349–1353.

    Article  PubMed  Google Scholar 

  65. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387–1397.

    Article  PubMed  CAS  Google Scholar 

  66. van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A, Witteman JC. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med 2003;163:1323–1328.

    Article  PubMed  Google Scholar 

  67. Tall AR, C-reactive protein reassessed. N Engl J Med 2004;350:1450–1452.

    Article  PubMed  CAS  Google Scholar 

  68. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 2003;290:932–940.

    Article  PubMed  Google Scholar 

  69. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827–832.

    PubMed  CAS  Google Scholar 

  70. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101:850–855.

    PubMed  CAS  Google Scholar 

  71. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210–215.

    Article  PubMed  CAS  Google Scholar 

  72. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951–1953.

    PubMed  CAS  Google Scholar 

  73. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000;36:1253–1260.

    Article  PubMed  CAS  Google Scholar 

  74. Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults. Circulation 2003;107:2571–2576.

    Article  PubMed  Google Scholar 

  75. Möhlenkamp S, Lehmann N, Schmermund A, et al. Prognostic value of extensive coronary calcium quantities in symptomatic males — a 5-year followup study. Eur Heart J 2003;24:845–854.

    Article  PubMed  Google Scholar 

  76. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003;228:826–833.

    Article  PubMed  Google Scholar 

  77. Vliegenthart R, Oudkerk M, Song B, van der Kuip DA, Hofman A, Witteman JC. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J 2002;23:1596–1603.

    Article  PubMed  CAS  Google Scholar 

  78. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002;39:225–230.

    Article  PubMed  Google Scholar 

  79. Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 2000;86:495–498.

    Article  PubMed  CAS  Google Scholar 

  80. Taylor AJ, Burke AP, O’Malley PG, et al. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation 2000;101:1243–1248.

    PubMed  CAS  Google Scholar 

  81. Taylor AJ, Feuerstein I, Wong H, Barko W, Brazaitis M, O’Malley PG. Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project. Am Heart J 2001;141:463–468.

    Article  PubMed  CAS  Google Scholar 

  82. Hecht HS, Superko HR, Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women. J Am Coll Cardiol 2001;37:1506–1511.

    Article  PubMed  CAS  Google Scholar 

  83. Hunt ME, O’Malley PG, Vernalis MN, Feuerstein IM, Taylor AJ. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 2001;141:206–210.

    Article  PubMed  CAS  Google Scholar 

  84. Reilly MP, Wolfe ML, Localio AR, Rader DJ. C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003;23:1851–1856.

    Article  PubMed  CAS  Google Scholar 

  85. Schmermund A, Stang A, Moebus S, et al. Is there an association of high-sensitive C-reactive protein with coronary calcium? The Heinz Nixdorf RECALL Study. J Am Coll Cardiol 2004;43(Suppl A):334A.

    Google Scholar 

  86. Oei HH, Vliegenthart R, Hofman A, Oudkerk M, Witteman JC. Risk factors for coronary calcification in older subjects. The Rotterdam Coronary Calcification Study. Eur Heart J 2004;25:48–55.

    Article  PubMed  Google Scholar 

  87. Schmermund A, Lehmann N, Möhlenkamp S, et al. Independent information provided by Framingham risk algorithm and coronary calcium scores in a large German population sample: Heinz Nixdorf RECALL Study. J Am Coll Cardiol 2004;43(Suppl. A):334A.

    Google Scholar 

  88. Desai MY, Nasir K, Braunstein JB, et al. Framingham risk estimate is weakly correlated with coronary artery calcification in asymptomatic population. J Am Coll Cardiol 2004;43(Suppl A):363A.

    Article  Google Scholar 

  89. Achenbach S, Nomayo A, Couturier G, et al. Relation between coronary calcium and 10-year risk scores in primary prevention patients. Am J Cardiol 2003;92:1471–1475.

    Article  PubMed  CAS  Google Scholar 

  90. Arad Y, Newstein D, Roth M, Guerci AD. Rationale and design of the St. Francis Heart Study: a randomized clinical trial of atorvastatin plus antioxidants in asymptomatic persons with elevated coronary calcification. Control Clin Trials 2001;22:553–572.

    Article  PubMed  CAS  Google Scholar 

  91. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154–2169.

    Article  PubMed  Google Scholar 

  92. Thompson GR, Partridge J, Coronary calcification score: the coronary-risk impact factor. Lancet 2004;363:557–559.

    Article  PubMed  CAS  Google Scholar 

  93. Lichtman JH, Amatruda J, Yaari S, et al. Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease. Am Heart J 2004;147:522–528.

    Article  PubMed  Google Scholar 

  94. Kline-Rogers EM, Eagle KA. It takes more than patient education to reach low-density lipoprotein cholesterol goals. Am Heart J 2004;147:381–382.

    Article  PubMed  Google Scholar 

  95. Kalia NK, Miller LG, Budoff MJ. Higher coronary calcification scores improve adherence to cardiac risk factor-modifying behaviors. J Am Coll Cardiol 2004. 43:363A (abstract).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Cardiology Practice and Hospital, Munich, Germany

    Sigmund Silber MD, FACC, FESC

  2. Department of Cardiology, Technical University of Munich Munich Rehabilitation Center, München, Germany

    Peter Mathes MD, FACC, FESC

Authors
  1. Sigmund Silber MD, FACC, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Mathes MD, FACC, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Public Health Department, Kalmar County, Oskarshamn, Sweden

    Joep Perk FESC

  2. Klinische Kardiologie II, Herz-Zentrum Bad Krozingen, Germany

    Helmut Gohlke FACC, FESC

  3. Institute of Health Sciences Department of Earth Sciences, Vrije University, Amsterdam, The Netherlands

    Irene Hellemans MD, (Speciality Cardiology), PhD

  4. Department of Cardiology, Vrije University Medical Center, Amsterdam, The Netherlands

    Irene Hellemans MD, (Speciality Cardiology), PhD

  5. Hôpital Broussais-HEGP, Assistance Publique-Hôpitaux de Paris, Paris, France

    Philippe Sellier MD

  6. Department of Cardiology, Technical University of Munich Munich Rehabilitation Center, München, Germany

    Peter Mathes MD, FACC, FESC

  7. Cardiac Rehabilitation Center, Bois Gilbert, Ballan Miré, France

    Catherine Monpère MD

  8. Department of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland

    Hannah McGee BA(Mod), PhD, RegPsycholFPsSI

  9. Swiss Cardiovascular Center Bern Cardiovascular Prevention and Rehabilitation University, Hospital Inselspital, Switzerland

    Hugo Saner MD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

Silber, S., Mathes, P. (2007). New Concepts for Early Diagnosis of Coronary Artery Disease. In: Perk, J., et al. Cardiovascular Prevention and Rehabilitation. Springer, London. https://doi.org/10.1007/978-1-84628-502-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-502-8_11

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-462-5

  • Online ISBN: 978-1-84628-502-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation